ReviewInternational journal of molecular sciences2025

Immunotherapies Targeting CD123 and CD303: A New Frontier in Treating Blastic Plasmacytoid Dendritic Cell Neoplasm.

Domenico Galati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.